Merck Delivers Mixed 4Q Results
February 03, 2016 at 06:59 AM EST
Dow component Merck reported an adjusted 4Q profit of $0.93 per share, topping the estimate for $0.91. Revenue for the drugmaker came in at $10.2 billion, missing the estimate for $10.35 billion.
